Evidence map›Paper›PMID 21994768›Full record

ReviewViruses2011

Herpesviruses and intermediate filaments: close encounters with the third type.

Laura Hertel

Abstract readReview
In one paragraph

Review in Viruses, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Nuclear Egress.Current issues in molecular biology · 2021
    Review
  3. Review
  4. Review
  5. Journal of virology · 2017
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Laura HertelCenter for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, 5700 Martin Luther King Jr. Way, Oakland, CA 94609, USA. lhertel@chori.org

Funding

RASCAL: a new tropism determinant encoded by human cytomegalovirus?R21AI088481 · NIAID · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI HERTEL, LAURA · 2011 to 2012
$446k
NIAID NIH HHS R21 AI088481
6 · The paper itself

Abstract

Intermediate filaments (IF) are essential to maintain cellular and nuclear integrity and shape, to manage organelle distribution and motility, to control the trafficking and pH of intracellular vesicles, to prevent stress-induced cell death, and to support the correct distribution of specific proteins. Because of this, IF are likely to be targeted by a variety of pathogens, and may act in favor or against infection progress. As many IF functions remain to be identified, however, little is currently known about these interactions. Herpesviruses can infect a wide variety of cell types, and are thus bound to encounter the different types of IF expressed in each tissue. The analysis of these interrelationships can yield precious insights into how IF proteins work, and into how viruses have evolved to exploit these functions. These interactions, either known or potential, will be the focus of this review.

Indexed as

AnimalsHerpesviridaeHerpesviridae InfectionsHumansIntermediate Filament ProteinsIntermediate FilamentsIntermediate Filament ProteinscytomegaloviruscytoskeletonEpstein-Barr virusherpes simplex virusherpesvirusinfectionintermediate filamentKaposi’s sarcoma associated herpesvirusvaricella zoster virus

Identifiers

PMID21994768
PMCPMC3185793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.